BIO-PATH HOLDINGS INC BPTH Cash Flow

Bio-path holdings inc (BPTH)

CashFlow / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11
Cash flow from operating activities
Net loss
-3,324	-2,389	-2,242	-2,456	-1,512	-1,909	-3,081	-1,677	-1,916	-2,167	-2,474	-1,985	-397	-1,371	-1,570	-1,942	-1,867	-1,459	-1,508	-1,125	-1,375	-1,596	-1,148	-1,268	-504	-789	-1,393	-427	-656	-431	-840	-787	-522	-804	-503	-462	-592
Adjustments to reconcile net loss to net cash used in operating activities
Technology impairment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	345	0	-	-	-	-
Common stock issed for services
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	18	0	-	-	-	-
Stock-based compensation
170	162	184	181	157	138	153	139	124	118	168	258	249	234	232	223	95	86	99	92	92	76	118	122	86	68	606	13	16	17	11	14	19	19	122	120	119
Amortization of technology license
-	-	-	-	-	40	41	40	40	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of right of use assets
19	21	19	28	28	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization
-	-	-	-	-	-	-	-	-	40	40	40	40	40	41	40	40	40	41	40	40	40	40	40	40	40	40	40	40	40	48	48	48	54	53	52	51
Depreciation
18	18	17	33	66	67	66	66	66	66	77	75	33	12	10	11	10	10	10	11	10	10	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of warrant liability
-	-	-	-	-	-	-	-	-	0	0	-778	-1,596	-293	-1,420	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
(Increase) decrease in operating assets
Prepaid drug product for testing
-12	11	111	227	95	75	-1,075	76	139	464	61	215	1	180	-383	-32	51	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Grants receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	488	0	0	-244
Prepaid drug product for testing
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	337	204	-	-44	-107	197	-96	-130	183	-99	115	-215	10	132	23	0	0	-88
Other current assets
-250	49	-106	-528	570	522	-323	274	-23	-158	-500	149	-40	-10	-364	526	571	-21	-53	131	22	-94	22	14	93	14	3	-7	11	-2	-1	5	-7	45	6	-5	-21
Increase (decrease) in operating liabilities
Accounts payable and accrued expenses
341	19	141	-274	-54	370	-48	76	138	24	221	-49	-208	-75	53	-87	-37	456	-211	76	54	278	-50	-86	125	121	-94	-22	-38	60	25	-3	-69	111	-15	32	-58
Lease liabilities
21	16	7	28	28	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Lease liabilities
-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-2,249	-2,381	-1,001	-1,225	-1,374	-1,405	-1,155	-1,018	-1,098	-544	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in operating activities
-2,535	-2,245	-1,893	-2,215	-2,008	-1,283	-1,471	-1,706	-1,664	-2,225	-1,529	-2,363	-1,840	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-551	-	-538	-629	-400	-423	-350	-250	-124
Cash flow from investing activities
Purchase of exclusive license - related party
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	25	107	25	5	32
Purchases of furniture, fixtures & equipment
-	-	-	-	-	0	0	0	17	0	0	114	424	313	25	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in investing activities
-	-	-	-	-	0	0	0	-17	0	0	-114	-424	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	-25	-107	-25	-5	-32
Cash flow from financing activities
Proceeds from convertible notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	-	-	-
Cash repayment of convertible notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	-	-	-
Net proceeds from sale of common stock
0	7,289	0	0	19,411	1	1,179	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	13,812	-72	2,887	2,210	305	627	708	214	49	500	137	711	684
Net proceeds from exercise of warrants
0	0	169	45	869	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by financing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	434	0	0	13,812	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by financing activities
0	7,289	169	45	20,280	1	1,179	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	305	-	708	214	49	500	137	711	684
Net increase (decrease) in cash
-2,535	5,044	-1,724	-2,170	18,272	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Supplemental disclosure of non-cash activities
Non-cash investing activities
Net increase (decrease) in cash
-	-	-	-	-	-	-	-	-1,681	1,342	-1,559	-929	-2,264	-1,924	7,075	-2,249	-2,381	-1,001	-1,225	-1,374	-1,405	-777	-1,084	-1,098	13,267	-549	2,173	1,638	-245	201	170	-414	-375	-31	-238	455	527
Interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	-	-	-	-
Income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0	0
Capital expenditures included in accrued expenses
-	-	-	-	-	-	-	-	-	-	-	-	114	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Common stock issued upon conversion of convertible notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	-	-	-